menu
    • menu
    [{"orgOrder":0,"company":"Vesalius Therapeutics","sponsor":"GSK","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"U.S.A","productType":"Small molecule","year":"2024","type":"Agreement","leadProduct":"Undisclosed","moa":"","graph1":"Neurology","graph2":"Discovery Platform","graph3":"Vesalius Therapeutics","amount2":0.65000000000000002,"highestDevelopmentShortName":"Discovery Platform","therapeuticAreaShortName":"Neurology","amount2New":0.65000000000000002,"dosageForm":"","sponsorNew":"Vesalius Therapeutics \/ GSK","highestDevelopmentStatusID":"3","companyTruncated":"Vesalius Therapeutics \/ GSK"}]

    Find Clinical Drug Pipeline Developments & Deals by Vesalius Therapeutics

    Menu

    Vesalius Therapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Vesalius Therapeutics

                            U.S.A arrow
                            Cosmoprof
                            Not Confirmed

                            Vesalius Therapeutics

                            U.S.A arrow
                            Cosmoprof
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Neurology

                            Study Phase : Discovery Platform

                            Sponsor : GSK

                            Deal Size : $650.0 million

                            Deal Type : Agreement

                            DEALS_DEV arrow-down

                            Vesalius and GSK Partner for Parkinson's Breakthrough Treatments

                            Details : Under the terms of agreement, Vesalius will leverage its platform to identify novel intervention in Parkinson's disease and GSK have the option to advance programs against those intervention points.

                            Brand Name : Undisclosed

                            Molecule Type : Small molecule

                            Upfront Cash : $80.0 million

                            November 12, 2024

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Neurology

                            Highest Development Status : Discovery Platform

                            Sponsor : GSK

                            Deal Size : $650.0 million

                            Deal Type : Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth